[{"Assets_0_Q2_USD":259123000.0,"CommonStockSharesOutstanding_0_Q2_shares":36917723.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-47701000.0,"NetIncomeLoss_1_Q2_USD":-34080000.0,"NetIncomeLoss_2_Q2_USD":-69118000.0,"StockholdersEquity_0_Q2_USD":209855000.0,"Ticker":"RVNC","CIK":"1479290","name":"REVANCE THERAPEUTICS, INC.","OfficialName":"Revance Therapeutics Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1265045755.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180803"}]